Search

Author/Creator Ku, Ja Hyeon

2. De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study. (27th August 2019)

Authors:
Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon
Other Names:
Cochetti Giovanni Guest Editor.
Journal:
Disease markers
Issue:
Volume 2019(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dose, duration and strain of bacillus Calmette–Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials. Issue 42 (October 2017)

Authors:
Quan, Yongjun; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Kim, Hyung Suk; Ku, Ja Hyeon
Other Names:
Mubarak. Muhammed section editor.
Journal:
Medicine
Issue:
Volume 96:Issue 42(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Editorial Comment from Dr Kim and Dr Ku to Prognostic factors of recurrent disease in upper urinary tract urothelial cancer after radical nephroureterectomy: Subanalysis of the multi‐institutional national database of the Japanese Urological Association. (4th August 2015)

Authors:
Kim, Hyung Suk; Ku, Ja Hyeon
Journal:
International journal of urology
Issue:
Volume 22:Number 11(2015)
Page Start:
1021
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial. Issue 10 (15th October 2020)

Authors:
Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon; Moon, Kyung Chul; Ku, Ja Hyeon
Journal:
BMJ open
Issue:
Volume 10:Issue 10(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial. Issue 10 (15th October 2020)

Authors:
Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon; Moon, Kyung Chul; Ku, Ja Hyeon
Journal:
BMJ open
Issue:
Volume 10:Issue 10(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial. Issue 10 (15th October 2020)

Authors:
Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon; Moon, Kyung Chul; Ku, Ja Hyeon
Journal:
BMJ open
Issue:
Volume 10:Issue 10(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Efficacy of neoadjuvant atezolizumab treatment in patients with advanced urothelial bladder cancer according to the BASQ classification: a study protocol for an open-label, two-cohort, phase II trial. Issue 10 (15th October 2020)

Authors:
Yuk, Hyeong Dong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon; Moon, Kyung Chul; Ku, Ja Hyeon
Journal:
BMJ open
Issue:
Volume 10:Issue 10(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗